Eugene Rhee, MD

Endocrine/Nephrology Unit: Rhee Laboratory

The Eugene Rhee Laboratory is interested in several aspects of renal metabolism, with the goal to understand how alterations in energy metabolism contribute to kidney disease pathogenesis and its complications and to discover metabolite markers of CKD and its progression.


Our laboratory is jointly supported by the Endocrine and Nephrology Divisions of the Department of Medicine. Our studies on metabolism and renal disease extend naturally from this collaboration and span epidemiologic, physiologic, and experimental approaches, with an emphasis on liquid chromatography, mass spectrometry based metabolomics. Current projects include: 1.) discovery of metabolite predictors of incident CKD, CKD progression, and cardiovascular outcomes in well-characterized clinical cohorts, 2.) characterization of novel renal metabolic functions using samples acquired with invasive catheterization, and 3.) animal and cell based studies to test the functional effects of select metabolites and metabolic pathways. We are interested both in metabolites that are important locally for maintaining kidney cell health as well as metabolites that may have a systemic role in metabolism, e.g. in phosphate homeostasis.


  1. Rhee EP, Souza A, Farrell L, Pollak MR, Lewis GD, Steele DJ, Thadhani R, Clish CB, Greka A, Gerszten RE. Metabolite Profiling Identifies Markers of Uremia. J Am Soc Nephrol 2010; 32(6):1041-51.
  2. Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, McCabe E, Yang E, Farrell L, Fox CS, O’Donnell CJ, Carr SA, Vasan RS, Florez JC, Clish CB, Wang TJ, Gerszten RE. Lipid Profiling Identifies a Triacylglycerol Signature of Insulin Resistance and Improves Diabetes Prediction in Humans. J Clin Invest 2011; 121(4):1402-11.
  3. Rhee EP, Clish CB, Ghorbani A, Larson MG, Elmariah S, McCabe E, Yang Q, Cheng S, Pierce K, Deik A, Souza AL, Farrell L, Domos C, Yeh RW, Palacios I, Rosenfield K, Vasan RS, Florez JC, Wang TJ, Fox CS, Gerszten RE. A Combined Epidemiologic and Metabolomic Approach Improves Chronic Kidney Disease Prediction. J Am Soc Nephrol 2013; 24(8):1330-8.
  4. Rhee EP,* Ho JE,* Chen MH,* Shen D, Cheng S, Larson MG, Ghorbani A, Shi X, Helenius IT, O’Donnell CJ, Souza AL, Deik A, Pierce KA, Bullock K, Walford GA, Vasan RS, Florez JC, Clish CB, Yeh JR, Wang TJ, Gerszten RE. A Genome-Wide Association Study of the Human Metabolome in a Community Based Cohort. Cell Metab 2013; 18(1):130-43. *equal contribution
  5. Kalim S, Clish CB, Wenger J, Elmariah S, Yeh RW, Deferio J, Pierce K, Deik A, Gerszten RE, Thadhani R, Rhee EP. A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients. J Am Heart Assoc 2013; 2(6):e000542
  6. van Ballegooijen AJ, Rhee EP, Elmariah S, de Boer IH, Kestenbaum B. Renal Clearance of Mineral Metabolism Markers. J Am Soc Nephrol 2016; 27(2): 392-97.


Contact Us

Eugene Rhee, MD

Thier Research Building 1051

50 Blossom Street Boston, MA 02114
  • Near Public Transit
  • Accessible

Assistant Professor of Medicine

Back to Top